Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $506.63 USD
Change Today -7.25 / -1.41%
Volume 774.8K
As of 8:10 PM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard S. Schleifer M.D., Ph.D.

Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 109 board members in 2 different organizations across 1 different industries.

See Board Relationships
61$41,965,424
As of Fiscal Year 2014

Background*

Dr. Leonard S. Schleifer, M.D., Ph.D. founded Regeneron Pharmaceuticals, Inc. in 1988 and has been President and Chief Executive Officer since 1988. Dr. Schleifer served as the Chairman of Regeneron Pharmaceuticals from 1990 to 1994. In 1992, Dr. Schleifer was appointed Clinical Professor of Neurology at the Cornell University Medical School, and from 1984 to 1988 he served as an Assistant Professor of the Cornell University Medical School in the Departments of Neurology ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-847-7000
Fax: --

Board Members Memberships*

Director
1988-Present
Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee

Education*

PhD
University of Virginia
MD
University of Virginia

Other Affiliations*

Annual Compensation*

Salary$1,071,200
Bonus$2,142,400
Total Annual Compensation$3,213,600

Stock Options*

All Other Compensation$107,124
Exercised Options256,808
Exercised Options Value$98,431,794
Exercisable Options2,005,118
Exercisable Options Value$727,583,667
Unexercisable Options563,125
Unexercisable Options Value$74,051,056
Total Value of Options$900,066,516
Total Number of Options2,825,051

Total Compensation*

Total Annual Cash Compensation$3,320,724
Total Short Term Compensation$3,213,600
Other Long Term Compensation$107,124
Total Calculated Compensation$41,965,424
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $506.63 USD -7.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
--
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.